Acceder

Publicaciones - Grupo de radiofarmacia

Cargando...
Ruiz-Alcaraz AJ, Nunez-Sanchez MA, Asensio Ruiz MA, Martinez-Sanchez MA, Oliva-Bolarin A, Martinez Martinez T, Perez Cuadrado JJ, Ramos-Molina B, Lozano-Perez AA. Optimizing the Preparation of Silk Fibroin Nanoparticles and Their Loading with Polyphenols: Towards a More Efficient Anti-Inflammatory Effect on Macrophages. Pharmaceutics. 2023 Jan 12;15(1):263. doi: 10.3390/pharmaceutics15010263. PubMed PMID: 36678894; PubMed Central PMCID: PMC9861267.
AÑO: 2023; IF: 4.9
36678894
Asensio Ruiz MA, Alonso Garcia A, Bravo-Ferrer Moreno ML, Cebreiros-Lopez I, Noguera-Velasco JA, Lozano-Perez AA, Martinez Martinez T. In Vitro Hemocompatibility and Genotoxicity Evaluation of Dual-Labeled [99mTc]Tc-FITC-Silk Fibroin Nanoparticles for Biomedical Applications. Pharmaceuticals (Basel). 2023 Feb 7;16(2):248. doi: 10.3390/ph16020248. PubMed PMID: 37259395; PubMed Central PMCID: PMC9959965.
AÑO: 2023; IF: 4.3
37259395
Asensio Ruiz MA, Fuster MG, Martinez Martinez T, Montalban MG, Cenis JL, Villora G, Lozano-Perez AA. The Effect of Sterilization on the Characteristics of Silk Fibroin Nanoparticles. Polymers (Basel). 2022 Jan 26;14(3):498. doi: 10.3390/polym14030498. PubMed PMID: 35160487; PubMed Central PMCID: PMC8840090.
AÑO: 2022; IF: 4.967
35160487
Ferri JM, Aldas M, Rayon E, Samper MD, Lozano-Perez AA. The Influence of Different Sustainable Silk-Based Fillers on the Thermal and Mechanical Properties of Polylactic Acid Composites. Polymers (Basel). 2022 Nov 18;14(22):5016. doi: 10.3390/polym14225016. PubMed PMID: 36433143; PubMed Central PMCID: PMC9695667.
AÑO: 2022; IF: 4.967
36433143
Hcini K, Bahi A, Zarroug MB, Farhat MB, Lozano-Perez AA, Cenis JL, Quilez M, Stambouli-Essassi S, Jordan MJ. Polyphenolic Profile of Tunisian Thyme (Thymbra capitata L.) Post-Distilled Residues: Evaluation of Total Phenolic Content and Phenolic Compounds and Their Contribution to Antioxidant Activity. Molecules. 2022 Dec 12;27(24):8791. doi: 10.3390/molecules27248791. PubMed PMID: 36557924; PubMed Central PMCID: PMC9780846.
AÑO: 2022; IF: 4.927
36557924
Siguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

Grupo de radiofarmacia